Morpholine Bioisosteres for Drug Design
More than 20 FDA-approved drugs contain the morpholine moiety, although it is often metabolically labile. Morpholine-based analogues may advantageously alter important pharmacokinetic properties such as lipophilicity and metabolic stability when grafted onto molecular scaffolds. Herein we have designed and synthesized a library of morpholine analogues for drug design.
Design
